Janssen has expressed mixed feelings to the Appraisal Consultation Document1 (ACD) from the National Institute of Health and Care Excellence (NICE) for the use of Olysio® (simeprevir).
Pfizer has announced grant donations of approximately $2 million to provide support for African immunisation projects.
Boehringer Ingelheim has announced an exclusive global license and development collaboration with CureVac that will involve the creation of a new lung cancer therapy.
A Gwent hospital may be forced to close it’s A&E department over night as junior doctors are withdrawn from work.
Novo Nordisk’s diabetes combination drug has been given the green light for marketing across the EU.
NHS England chief executive Simon Stevens has deemed obesity ‘the new smoking’, calling for urgent action to promote good health.
Janssen’s hepatitis C drug has been approved by NICE for use across the NHS in a limited capacity.
Merck Serono and Sutro Biopharma have entered an alliance to develop ADCs for cancer treatment.
National Institute for Health and Care Excellence (NICE) has fast-tracked its recommendation for a third new drug for melanoma, from GlaxoSmithKline (GSK), after the pharma firm offered to supply it at a discounted price to the NHS.
The NICE Board yesterday considered proposals on Value Based Assessment (VBA) following a three month consultation.
The BMA Wales has warned the NHS faces “imminent meltdown”, calling for an urgent independent enquiry.
Exp. Medical Reps and trainees. KAMs; eDetailing Reps Nationwide Opportunities
Click here to apply now!
“Opportunities nationwide with Boehringer Ingelheim”
Nationwide Sales and Marketing Opportunities available
Click here to apply!
No running polls, please check backsoon.
Increase your knowledge. Browse the Pf Archive.
Read Pf now
Looking to make a move? Find your next job here.
click here to createan account
Need career advice? Visit our Career Centre.